Versant Side Fund Ii, Lp - Net Worth and Insider Trading

Versant Side Fund Ii, Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Versant Side Fund Ii, Lp owns 7 companies in total, including Inogen Inc (INGN) , Second Sight Medical Products Inc (EYES) , and Achaogen Inc (AKAOQ) among others .

Click here to see the complete history of Versant Side Fund Ii, Lp’s form 4 insider trades.

Insider Ownership Summary of Versant Side Fund Ii, Lp

Ticker	Comapny	Transaction Date	Type of Owner
INGN	Inogen Inc	2014-02-12	10 percent owner
EYES	Second Sight Medical Products Inc	2014-11-18	10 percent owner
AKAOQ	Achaogen Inc	2014-03-17	10 percent owner
		2013-10-11	10 percent owner
		2006-05-09	10 percent owner
		2006-03-13	other: Former 10% Holder
		2014-11-18	10 percent owner

Versant Side Fund Ii, Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Versant Side Fund Ii, Lp Ownership Network

Ownership Network List of Versant Side Fund Ii, Lp

No Data

Ownership Network Relation of Versant Side Fund Ii, Lp

Versant Side Fund Ii, Lp Owned Company Details

What does Inogen Inc do?

Who are the key executives at Inogen Inc?

Versant Side Fund Ii, Lp is the 10 percent owner of Inogen Inc. Other key executives at Inogen Inc include EVP & Gen. Counsel & Secretary Jason Somer , EVP & Chief Medical Officer Stanislav Glezer , and EVP & CFO and Treasurer Kristin A. Caltrider .

Inogen Inc (INGN) Insider Trades Summary

Over the past 18 months, Versant Side Fund Ii, Lp made no insider transaction in Inogen Inc (INGN). Other recent insider transactions involving Inogen Inc (INGN) include a net sale of 10,000 shares made by Jason Somer ,

In summary, during the past 3 months, insiders sold 0 shares of Inogen Inc (INGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10,000 shares of Inogen Inc (INGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 10,000 shares.

Inogen Inc (INGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inogen Inc Insider Transactions

No Available Data

What does Second Sight Medical Products Inc do?

Who are the key executives at Second Sight Medical Products Inc?

Versant Side Fund Ii, Lp is the 10 percent owner of Second Sight Medical Products Inc. Other key executives at Second Sight Medical Products Inc include Chief Medical Officer Lisa Ellen Porter , Chief Business Officer Donald Dwyer , and COO Truc Le .

Second Sight Medical Products Inc (EYES) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Second Sight Medical Products Inc (EYES) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Second Sight Medical Products Inc (EYES) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Second Sight Medical Products Inc (EYES)'s detailed insider trading history can be found in Insider Trading Tracker table.

Second Sight Medical Products Inc Insider Transactions

No Available Data

What does Achaogen Inc do?

Who are the key executives at Achaogen Inc?

Versant Side Fund Ii, Lp is the 10 percent owner of Achaogen Inc. Other key executives at Achaogen Inc include 10 percent owner Robert W Duggan , Chief Operating Officer Elizabeth Bhatt , and See Remarks Gary Loeb .

Achaogen Inc (AKAOQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Achaogen Inc (AKAOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achaogen Inc (AKAOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achaogen Inc (AKAOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Achaogen Inc Insider Transactions

No Available Data

What does CymaBay Therapeutics Inc do?

Who are the key executives at CymaBay Therapeutics Inc?

Versant Side Fund Ii, Lp is the 10 percent owner of CymaBay Therapeutics Inc. Other key executives at CymaBay Therapeutics Inc include Chief Scientific Officer Charles Mcwherter , Vice President & Finance Daniel Menold , and General Counsel Paul T Quinlan .

CymaBay Therapeutics Inc (CBAY) Insider Trades Summary

Over the past 18 months, Versant Side Fund Ii, Lp made no insider transaction in CymaBay Therapeutics Inc (CBAY). Other recent insider transactions involving CymaBay Therapeutics Inc (CBAY) include a net sale of 171,559 shares made by Charles Mcwherter , a net sale of 93,000 shares made by Paul T Quinlan , and a net sale of 52,442 shares made by Daniel Menold .

In summary, during the past 3 months, insiders sold 0 shares of CymaBay Therapeutics Inc (CBAY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 481,646 shares of CymaBay Therapeutics Inc (CBAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 481,646 shares.

CymaBay Therapeutics Inc (CBAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

CymaBay Therapeutics Inc Insider Transactions

No Available Data

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Versant Side Fund Ii, Lp is the 10 percent owner of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

Over the past 18 months, Versant Side Fund Ii, Lp made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 48,967 shares made by Evan Loh , a net sale of 34,526 shares made by William M. Haskel , and a net sale of 31,250 shares made by Michael Bigham .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 142,346 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

What does Alexza Pharmaceuticals Inc do?

Who are the key executives at Alexza Pharmaceuticals Inc?

Versant Side Fund Ii, Lp is the other: Former 10% Holder of Alexza Pharmaceuticals Inc. Other key executives at Alexza Pharmaceuticals Inc include director & President & CEO Thomas Braxton King , Former SVP & CFO & Secretary Mark K Oki , and EVP & Operations & COO Robert A Lippe .

Alexza Pharmaceuticals Inc (ALXA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alexza Pharmaceuticals Inc (ALXA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexza Pharmaceuticals Inc (ALXA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexza Pharmaceuticals Inc (ALXA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alexza Pharmaceuticals Inc Insider Transactions

No Available Data

What does Vivani Medical Inc do?

Who are the key executives at Vivani Medical Inc?

Versant Side Fund Ii, Lp is the 10 percent owner of Vivani Medical Inc. Other key executives at Vivani Medical Inc include Chief Business Officer Donald Dwyer , director & 10 percent owner Gregg Williams , and CFO Brigid Makes .

Vivani Medical Inc (VANI) Insider Trades Summary

Over the past 18 months, Versant Side Fund Ii, Lp made no insider transaction in Vivani Medical Inc (VANI). Other recent insider transactions involving Vivani Medical Inc (VANI) include a net purchase of 727,608 shares made by Gregg Williams , a net purchase of 40,000 shares made by Donald Dwyer , and a net purchase of 15,000 shares made by Brigid Makes .

In summary, during the past 3 months, insiders sold 0 shares of Vivani Medical Inc (VANI) in total and bought 2,500 shares, with a net purchase of 2,500 shares. During the past 18 months, 0 shares of Vivani Medical Inc (VANI) were sold and 792,608 shares were bought by its insiders, resulting in a net purchase of 792,608 shares.

Vivani Medical Inc (VANI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vivani Medical Inc Insider Transactions

No Available Data

Versant Side Fund Ii, Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Versant Side Fund Ii, Lp. You might contact Versant Side Fund Ii, Lp via mailing address: One Sansome Street, Suite 3630, San Francisco Ca 94104.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.